Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

Clinical trial NCT01015521 · WITHDRAWN

Trial details

NCT number: NCT01015521
Sponsor: Tigris Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2010-04-01
Primary completion: 2012-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.